Company Directory > CRO > Aquitaine Science Transfert (SATT Aquitaine)
Aquitaine Science Transfert (AST) is a French Technology Transfer Office (TTO) acting as an accelerator for innovation. Its mission is to generate economic and social value from public research by facilitating the maturation of research results, managing intellectual property, and transferring technologies to companies through licensing or the creation of startups. AST operates as the first link in the innovation chain, investing in high-potential research projects to demonstrate proof of concept. It covers various sectors including health, biotechnology, medical devices, engineering sciences, and green technologies, supporting the transition from academic laboratories to the market.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:Technology Transfer Office / Research Accelerator
SIZE & FINANCIALS
Employees:51-200
Ownership:nonprofit
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Small molecule, mAb, Cell therapy, Gene therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:INSERM, Université de Bordeaux, Réseau SATT (National TTO Network)
COMPETITION
Position:Niche Player
Competitors:Other French SATTs (Sociétés d'Accélération du Transfert de Technologies), Ascenion, EMBLEM Technology Transfer
LEADERSHIP
Key Executives:
Maylis Chusseau - President
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aquitaine Science Transfert (SATT Aquitaine) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aquitaine Science Transfert (SATT Aquitaine). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.